NCT07203053
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07203053
Title A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2 (START-lung)
Acronym START-lung
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors ETOP IBCSG Partners Foundation
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | GRC | FRA | ESP | CHE

Facility Status City State Zip Country Details
CHU Angers Angers France Details
Institut Bergonie Bordeaux France Details
Lyon - Centre Léon Bérard Lyon France Details
Hôpital Nord de Marseille Marseille France Details
Henry Dunant Hospital Center Athens Greece Details
Irccs Irst Meldola Italy Details
Instituto Europeo di Oncologia (IEO) Milan Italy Details
Santa Maria della Misericordia Hospital Perugia Italy Details
AO San Giovanni Addolorata Roma Italy Details
Istituto Nazionale Tumori "Regina Elena" Roma Italy Details
Hospital General Universitario Alicante Alicante Spain Details
Hospital de la Santa Creu I Sant Pau Barcelona Spain Details
Hospital Universitatrio Vall d'Hebron Barcelona Spain Details
ICO Hospitalet H. Duran I Reynals / H. Bellvitge Barcelona Spain Details
Hospital Universitatrio Puerta del Hierro Madrid Spain Details
Kantonsspital Baden Baden Switzerland Details
HFR - Hôpital cantonal Fribourg Switzerland Details
Geneva University Hospitals Geneva Switzerland Details
Kantonsspital St.Gallen Sankt Gallen Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field